Findings from Federal University Sergipe in the Area of Myocardial Ischemia Reported (Technological Trends In Cyclodextrin Inclusion Complexes for Improving Cardiovascular Drug Therapy: a Patent Review).

A report from Federal University Sergipe in Brazil discusses the importance of developing new pharmacotherapies for ischemic heart disease to improve drug efficacy and safety. The study focuses on patents that utilize cyclodextrin inclusion complexes to enhance cardiovascular drug properties, particularly with herbal or traditional Chinese medicines. While cyclodextrins show promise in improving cardiovascular drug efficiency, further research is needed to validate their effectiveness through different molecular and cellular targets. The research emphasizes the potential of cyclodextrins and their derivatives in creating more effective formulations for cardiovascular disease treatment. [Extracted from the article]

Copyright of Heart Disease Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)